FB
Francis Burrows (Chief Scientific Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Kura Oncology, Inc. (KURA). The largest single filing was $232K of KURA (23,726 sh × $9.78, as filed), executed Dec 18 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$232K
shares × price, as filed
Last traded
Dec 18 2025
Filed Dec 19 2025
Median ADV $20.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $232K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
KURA
Kura Oncology, Inc.
KURA · 0 buys · 1 sell
1 filing
Recent filings
KURASALE
Kura Oncology, Inc.
View filing →
$232K23,726 sh × $9.78
Exec Dec 18 2025
Filed Dec 19 2025 · 5:30 PM ET